Agilon Health, Inc. (AGL) financial statements and ratios from SEC XBRL: revenue $5.9B (TTM), net margin -6.6%, revenue growth 7.2% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (latest FY) | $5.93B |
| Revenue (TTM) | $5.9B |
| Net Margin | -6.6% |
| Operating Margin (TTM) | -5.2% |
| Net Debt / EBITDA | 0.5 |
| Revenue Growth (YoY) | 7.2% |
| EPS Growth (YoY) | -117.0% |
| FCF Growth (YoY) | 58.5% |
| Price / Book | 7.05 |
| Price / Sales | 0.27 |
| FCF Yield | -5.3% |
| Altman Z-Score | 22.22 (safe) |
| Industry P/E (Healthcare Services) | 25.4 |
| Sector P/E (Healthcare) | 21.9 |
AGL overview · AGL earnings · AGL KPIs · AGL documents · AGL ownership · AGL peers
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.